ShEEP Request for Ultrasound Imaging System
ShEEP 请求超声成像系统
基本信息
- 批准号:9908741
- 负责人:
- 金额:--
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-09-01 至 2020-09-30
- 项目状态:已结题
- 来源:
- 关键词:11 year oldAdrenergic AgentsArteriesAtherosclerosisCardiacCardiovascular DiseasesChronic DiseaseClinicalColorComputer softwareDataData AnalysesDiagnosisDiseaseDoctor of PhilosophyEchocardiographyElectrocardiogramEquipmentFailureFrequenciesFundingGoalsHealthHealthcare SystemsHeartHeart failureHyperglycemiaImageImmuneInflammationLeft ventricular structureMedicineMicroRNAsMissionMonitorMusMyocardial IschemiaNamesOperative Surgical ProceduresPathogenesisPhysiciansPhysiologic pulsePost-Traumatic Stress DisordersResearchResolutionRespirationRight ventricular structureSamplingSan FranciscoScanningSheepSignal TransductionSystemTabletsTissuesTrainingTreatment FailureUltrasonographyUnited States National Institutes of HealthVentricularVeteransWorkagent orangeclinical practicedesigndiabeticexosomefootheart dimension/sizeheart functionhigh riskimaging softwareimaging systemimprovedinstrumentinstrumentationmid-career facultymouse modelnovelnovel strategiesnovel therapeuticsprofessorprogramsremote control
项目摘要
This request is for an Ultrasound Imaging System, the S-Sharp Corporation Prospect T1 High
Frequency Ultrasound Imaging System For Mice, with a 40 MHz probe, and an Indus Doppler Flow Velocity
System. This instrument will replace and upgrade our current mouse echocardiography system, a Siemans
Acuson S2000 Ultrasound System, with a 14 MHz probe. This old instrument was purchased in 2008 and is
now 11 years old. Image quality is deteriorating, and we are not able to get the detail and resolution we
require.
The requested ultrasound system will support 5 Major User PIs in 4 VA-funded projects. Each Major
User is working toward new treatments for heart failure, one of the most common, deadly clinical problems in
Veterans. The PIs use the echo system to assess the efficacy of potential treatments by quantifying the size
and function of the left and right ventricles and flow in the heart and main arteries.
The 5 PIs, all at the San Francisco VAMC, are as follows:
Paul C. Simpson, MD, Staff Cardiologist and Professor of Medicine, UCSF. His projects are “Novel
adrenergic mechanisms in heart failure therapy” (VA), and “An alpha-1A-adrenergic drug for heart failure”
(NIH).
Anthony J. Baker, PhD, Research Biologist SFVAHCS and Professor of Medicine, UCSF. His projects
are “Right Heart Function in Health and Chronic Disease” (VA), and “Novel Therapy for Right Ventricular
Failure” (UCSF).
Mary Nakamura, MD, Staff Physician and Professor of Medicine, UCSF, and co-PI Joel S. Karliner MD,
Staff Cardiologist and Professor of Medicine, UCSF. Their project is “Immune Mechanisms of Cardiac
Remodeling” (VA).
Robert Raffai, PhD, Research Biologist SFVAHCS and Associate Professor of Surgery, UCSF. His
projects are “Exosomes in the Pathogenesis of Diabetic Atherosclerosis & its Treatment Opportunities” (VA),
and “Hyperglycemia and MicroRNA Dysregulation of Inflammation in Atherosclerosis” (NIH).
The requested ultrasound system will enable and greatly enhance the work in the projects named
above, and hopefully facilitate the efforts to discover new treatments for heart failure.
本申请是针对S-夏普公司ProspectT1High的超声成像系统
40 MHz探头和Indus多普勒血流速度的小鼠频率超声成像系统
系统。这台仪器将取代和升级我们目前的鼠标超声心动图系统,西门子
Acuson S2000超声波系统,探头为14 MHz。这件旧乐器是在2008年购买的,现在
现在11岁了。图像质量正在恶化,我们无法获得我们需要的细节和分辨率
要求。
申请的超声系统将支持退伍军人管理局资助的4个项目中的5个主要用户PI。每个专业
USER正在研究治疗心力衰竭的新方法,心力衰竭是世界上最常见、最致命的临床问题之一
退伍军人。PI使用回声系统通过量化大小来评估潜在治疗的疗效
左、右心室的功能以及心脏和主要动脉的血流。
旧金山VAMC的5位PI如下:
保罗·C·辛普森,医学博士,加州大学旧金山分校心脏病专家和医学教授。他的项目是“新奇的”
心力衰竭治疗中的肾上腺素能机制“(VA),以及”一种治疗心力衰竭的肾上腺素能药物“
(美国国立卫生研究院)。
安东尼·贝克,博士,研究生物学家,加州大学旧金山分校医学教授。他的项目
《健康和慢性病中的右心功能》(VA)和《右室新疗法》
失败“(加州大学旧金山分校)。
Mary Nakamura,医学博士,加州大学旧金山分校内科教员兼医学教授,以及共同研究皮乔尔·S·卡林纳博士,
加州大学旧金山分校心脏病专家和医学教授。他们的项目是“心脏的免疫机制”
改建“(Va)。
罗伯特·拉法伊博士,加州大学旧金山分校研究生物学家兼外科副教授。他的
项目是“糖尿病动脉粥样硬化发病机制及其治疗机会中的外体”(VA),
和“高血糖和微RNA对动脉粥样硬化炎症的调节失调”(NIH)。
所要求的超声波系统将使以下项目的工作得以实现并大大加强
以上,并希望促进努力发现新的治疗心力衰竭的方法。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
PAUL C SIMPSON其他文献
PAUL C SIMPSON的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('PAUL C SIMPSON', 18)}}的其他基金
MYOCARDIAL RELAXATION AND CA++ TRANSPORT IN HYPERTROPHY
心肌肥厚时的心肌舒张和 CA 转运
- 批准号:
6151319 - 财政年份:1997
- 资助金额:
-- - 项目类别:
MYOCARDIAL RELAXATION AND CA++ TRANSPORT IN HYPERTROPHY
心肌肥厚时的心肌舒张和 CA 转运
- 批准号:
6351490 - 财政年份:1997
- 资助金额:
-- - 项目类别:
MYOCARDIAL RELAXATION AND CA++ TRANSPORT IN HYPERTROPHY
心肌肥厚时的心肌舒张和 CA 转运
- 批准号:
2872927 - 财政年份:1997
- 资助金额:
-- - 项目类别:
ALPHA-1 ADRENERGIC REGULATION OF CARDIAC GENE EXPRESSION
心脏基因表达的 ALPHA-1 肾上腺素调节
- 批准号:
2220319 - 财政年份:1989
- 资助金额:
-- - 项目类别:
A1-ADRENERGIC REGULATION OF CARDIAC GENE EXPRESSION
心脏基因表达的 A1-肾上腺素调节
- 批准号:
3360227 - 财政年份:1989
- 资助金额:
-- - 项目类别:
A1-ADRENERGIC REGULATION OF CARDIAC GENE EXPRESSION
心脏基因表达的 A1-肾上腺素调节
- 批准号:
3360228 - 财政年份:1989
- 资助金额:
-- - 项目类别:
ALPHA-1 ADRENERGIC REGULATION OF CARDIAC GENE EXPRESSION
心脏基因表达的 ALPHA-1 肾上腺素调节
- 批准号:
6030586 - 财政年份:1989
- 资助金额:
-- - 项目类别:
相似海外基金
Preclinical test for the efficacy of adrenergic agents in treatment of AD
肾上腺素能药物治疗AD疗效的临床前试验
- 批准号:
8358448 - 财政年份:2012
- 资助金额:
-- - 项目类别:
Preclinical test for the efficacy of adrenergic agents in treatment of AD
肾上腺素能药物治疗AD疗效的临床前试验
- 批准号:
8517552 - 财政年份:2012
- 资助金额:
-- - 项目类别:
MODULATING FLUID THERAPY WITH ADRENERGIC AGENTS AND CYCLIC AMP ENHANCERS IN
使用肾上腺素能药物和环放大器增强剂调节液体治疗
- 批准号:
7952159 - 财政年份:2009
- 资助金额:
-- - 项目类别:
THE EFFECT OF BETA-ADRENERGIC AGENTS AND FLUID THERAPY IN HUMANS
β-肾上腺素能药物和液体疗法对人体的影响
- 批准号:
7952152 - 财政年份:2009
- 资助金额:
-- - 项目类别:
MODULATING FLUID THERAPY WITH ADRENERGIC AGENTS AND CYCLIC AMP ENHANCERS IN
使用肾上腺素能药物和环放大器增强剂调节液体治疗
- 批准号:
7719194 - 财政年份:2008
- 资助金额:
-- - 项目类别:
THE EFFECT OF BETA-ADRENERGIC AGENTS AND FLUID THERAPY IN HUMANS
β-肾上腺素能药物和液体疗法对人体的影响
- 批准号:
7605416 - 财政年份:2007
- 资助金额:
-- - 项目类别:
MODULATING FLUID THERAPY WITH ADRENERGIC AGENTS AND CYCLIC AMP ENHANCERS IN
使用肾上腺素能药物和环放大器增强剂调节液体治疗
- 批准号:
7605425 - 财政年份:2007
- 资助金额:
-- - 项目类别:
THE EFFECT OF BETA-ADRENERGIC AGENTS AND FLUID THERAPY IN HUMANS
β-肾上腺素能药物和液体疗法对人体的影响
- 批准号:
7378753 - 财政年份:2006
- 资助金额:
-- - 项目类别:
Adrenergic Agents for Methamphetamine: Outpatient Trials
甲基苯丙胺肾上腺素药物:门诊试验
- 批准号:
6825160 - 财政年份:2004
- 资助金额:
-- - 项目类别: